Determinants of Response to Cardiac Resynchronization Therapy
John D Allison1, Yitschak Biton2, Theofanie Mela1
1The Demoulas Center for Cardiac Arrhythmias, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Insights
Cardiac resynchronization therapy (CRT) improves heart failure (HF) outcomes in select patients. Optimizing patient selection and device parameters can enhance CRT response rates, improving treatment efficacy for HF management.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is a standard treatment for heart failure (HF) patients with specific electrocardiographic and functional criteria.
- CRT effectively promotes reverse left ventricular (LV) remodeling and improves HF symptoms and clinical outcomes.
- A significant proportion of patients (approximately one-third) do not respond adequately to CRT.
Purpose of the Study:
- To review the key factors influencing patient response to CRT.
- To identify patient selection criteria and device-related parameters that optimize CRT efficacy.
- To provide insights into improving CRT response rates for better heart failure management.
Main Methods:
- Literature review of studies investigating CRT response.
- Analysis of factors including patient selection, LV lead placement, and device programming.
- Synthesis of evidence on optimizing atrioventricular and ventriculo-ventricular intervals.
Main Results:
- Patient selection is crucial for successful CRT outcomes.
- Left ventricular (LV) lead location and selection significantly impact CRT response.
- Optimization of pacing intervals (atrioventricular and ventriculo-ventricular) is associated with improved CRT response rates.
Conclusions:
- Several factors determine the success of CRT in heart failure patients.
- Careful patient selection and precise device optimization are essential for maximizing CRT benefits.
- Further research into refining CRT strategies can improve outcomes for non-responders.
Abstract:
Cardiac resynchronization therapy (CRT) is a well-established treatment modality for ambulatory patients with heart failure (HF) who have prolonged QRS, left bundle branch block, reduced left ventricular (LV) ejection fraction, and New York Heart Association class II-IV. CRT has been shown to induce reverse LV remodeling and improve HF symptoms and clinical outcomes. About one-third of CRT recipients are considered non-responders. Patient selection, LV lead location, LV lead selection, multipoint pacing, and optimization of the atrioventricular and ventriculo-ventricular intervals were all shown to be associated with a better CRT response rate. Herein, we review the determinants of CRT response.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Cardiac Performance
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure Drugs: Inotropic Agents


